FDA Drug · D-0403-2026

Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Guajarat, INDIA NDC 33342-401-44

Class II · Ongoing

Subpotent Drug

Affected lots / codes — check yours against thisLot 16240062A, exp date 3/2026

Recalling firm: MACLEODS PHARMA USA, INC, Princeton, NJ
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 1315 bottles
Distribution: Nationwide
Recall initiated: February 26, 2026
Classified: March 24, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0403-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →